Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-03-05 @ 7:57 AM
Study NCT ID:
NCT01886469
Status:
COMPLETED
Last Update Posted:
2014-10-03
First Post:
2013-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-21
First Submit QC Date:
None
Study First Post Date:
2013-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-02
Last Update Post Date:
2014-10-03
Last Update Post Date Type:
ESTIMATED